We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Arana Therap. | LSE:AAHX | London | Ordinary Share | AU000000AAH8 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 50.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:3151J Arana Therapeutics Limited 06 December 2007 For Immediate Release 6 December 2007 ARANA THERAPEUTICS LTD DIRECTOR'S SHARE PURCHASE Arana Therapeutics Ltd, (LSE: AAHx ASX: AAH) ("Arana" or the "Company"), the Australian biopharmaceutical company, formed through the merger of Peptech and EvoGenix in August 2007. The Company uses superior technology to develop next generation drugs that will improve the lives of patients with inflammatory diseases and cancer. The Company has received notification on 3 December 2007 that the following Director purchased ordinary fully paid shares in the capital of the Company. Details are as follows: Director Direct or No. of Date Price per Total Subsequent Indirect Ordinary Purchased Share (A$) Consideration beneficial Interest Shares (A$) holding purchased Robin Beaumont Indirect 13,352 3 December 2007 1.147 15,312 139,000 For further information, please contact: Arana Therapeutics Ltd Dr John Chiplin, Chief Executive Officer +61 (0)2 9870 8788 Niall Henderson, Chief Financial Officer +61 (0)2 9870 8788 Buchanan Communications Lisa Baderoon (lisab@buchanan.uk.com) +44 (0)20 7466 5000 Rebecca Skye Dietrich / Catherine Breen Nomura Code Securities Charles Walker +44 (0)20 7776 1206 This information is provided by RNS The company news service from the London Stock Exchange END RDSFSWSUMSWSEEE
1 Year Arana Therap. Chart |
1 Month Arana Therap. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions